Study of Nerve Reconstruction Using AVANCE in Subjects Who Undergo Robotic Assisted Prostatectomy for Treatment of Prostate Cancer

Exclusion Criteria

• •prior surgery in the last 6 months which could affect sexual function;
• •history of Peyronie's disease;
• •significant neurological disorder (i.e. multiple sclerosis, peripheral neuropathy);
• •treatment for major psychiatric disorders;
• •history of penile implant or prosthesis;
• •history of diabetic neuropathy;
• •life expectancy of less than two years;
• •concurrently involved in another investigational study;
• •uncontrolled hypertension with systolic BP \>200mmHg or diastolic BP \>115mmHg is present at screening;
• •currently receiving or planned treatment with chemotherapy or radiation therapy;
• •diagnosis of bony metastasis;
• •known allergy or severe intolerance to PDE-5 inhibitors; or
• •cardiac pacing equipment or other electro-mechanical devices which preclude the use of CaverMap™ neurostimulator.